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SS13.
Primary Non-synthetic AVFs (PAVF) for Long Term
venous Access (LTVA): Are Proximal AVF Access Proce-
dures Superior to Distal (DAVF) Access Interventions? A
5-Year Congruence Scrutiny Assessment Study
Sherif Sultan1,NaderHamada1,WaelTawfick1,NiamhHynes2.
1Vascular & Endovascular Surgery, Western Vascular Institute,
Galway, Ireland; 2Galway Clinic, Galway, Ireland
Objectives: Haemodialysis through LTVA is preferable
in ESRD patients because of the shorter duration of dialysis.
We aim to compare the outcome of PAVF to DAVF. Primary
endpoint is patency. Secondary endpoints are complication
rates, secondary intervention and mortality.
Methods: 179 patients with ESRD had 200 AVF forma-
tions from January 2003 to June 2009. 69% were males. Mean
age 53.6 years. All were upper limbs. All patients had duplex
ultrasound mapping of superficial veins prior to surgery. No
synthetic graftswereused.37proceduresweredistalAVF(radio-
cephalic) while 163 were proximal; either brachio-cephalic or
brachio-basilic.
Results: 1 year patency rate was 89% in proximal AVF
vs 22% distal (P0.0001).
Occlusive thrombosis occurred in 6% of PAVF
(n10/163), compared to 54% in DAVF (n20/37)
(P0.0001), with a significantly less need for re-interven-
tion (4% vs 32%) (P0.0001). PAVF had lower incidence
of non-occlusive thrombus (6%, n9/163) vs 24% (n9/
37) in DAVF P0.001. PAVF had reduced incidence of
aneurysm formation (12%, n19/163) vs 27% (n10/37)
in DAVF P0.033. 30 days mortality was 0.6% (n1/
163) in the PAVF group and 0% in the DAVF group. 5year
mortality was 7% (n12/163) in PAVF vs 30% (n11/37)
in DAVF patients (P0.0004).
Conclusions: PAVF is less tedious with greater blood flow
and easer manipulation for the nephrologists’ team. Venous
mapping prior to surgery with meticulous surgical techniques
increases patency. PAVF is established as a reliable proficient
procedure tobestow long-termaccess forhaemodialysiswith low
rates of infection. It has considerably less incidence of complica-
tions and re-interventions compared to DAVF. We believe that
PAVF must be offered as the first step in Long term venous
access.
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SS14.
Effects of Hemodialysis Duration and Access Location
on Hand Function
Gregory J. Landry, Zachary R. Krahn, Yves Vimegnon,
Sharon G. Kryger, Timothy K. Liem, Erica L. Mitchell,
Gregory L. Moneta. Oregon Health & Science University,
Portland, OR
Objectives: Chronic kidney disease (CKD) is associ-
ated with upper extremity functional decline. The mecha-
nism of decline and relationship to hemodialysis (HD)
access is not known. Access is conventionally placed in the
nondominant arm, partially due to concerns about the
effects on hand function. This study examines the effect of
HD duration and access location on hand function and
quality of life.
Methods: This is a cross-sectional study of CKD pa-
tients at varying stages of HD. Functional assessment of
strength (grip and pinch dynamometer), dexterity (Purdue
pegboard), sensation (Semmes-Weinstein monofilaments),
range of motion (ROM) (goniometer) and overall upper
extremity function (Sollerman test) was performed. Short
Form-36 (SF36), and Disability of the Arm, Shoulder, and
Hand (DASH) surveys were also completed. Five groups
were compared (pre-HD, 1 year HD, 1-3 years, 3-5
years, 5 years) with respect to changes in overall hand
function and the difference between the access and non-
access arms to isolate effects of HD access. Significance was
determined by Pearson’s r0.30, for which p0.05.
Results: 41 subjects (26 males; mean age 56.413.2
years) with CKD were enrolled (pre-HD  13, 1 year
HD 9, 1-3 years10, 3-5 years 6,5 years 3). Both
hands demonstrated significant declines in pinch strength
(r 0.36-0.50), finger and hand ROM (r0.32-0.60),
sensation (r0.30-0.41), and pegboard testing (r0.31-
0.53) with increasing HD duration. SF36 and DASH
scores did not correlate with HD duration. There was no
significant change in the difference between the non-HD
access arm and access arm across groups of differing HD
duration (r0.30 for all tests), indicating no effect of
HD access on unilateral hand function.
Conclusions: CKD patients experience an overall de-
cline in hand function over time that is independent of the
site ofHD access. The site of access may be chosen based on
optimal anatomy rather than hand dominance.
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Superficialization of Arteriovenous Fistulas Employing
Minimally Invasive Liposuction
Marlin W. Causey, Reagan Quan, Adam Hamawy, Niten
Singh. Madigan Army Medical Center, Ft. Lewis, WA
Background: Superficialization of arteriovenous fis-
tulas (AVFs) allow improved dialysis access for pro-
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longed utilization and more efficient dialysis treatment.
Multiple methods are described for superficializing arte-
riovenous fistulas and minimizing the surgical interven-
tion is advantageous for patient recovery and potentially
improved outcomes. We describe a novel technique em-
ploying a minimally invasive technique, liposuction, with
the use of ultrasonography to ensure the safety of the
AVF.
Technical Description: After identifying the AVF
using B mode duplex, tumescent anesthesia was admin-
istered under ultrasound guidance between the fistula
and subcutaneous tissues. After a short period of time (5
minutes) is allowed for epinephrine induced vasocon-
striction to occur and a 2 mm aspiration cannula is then
inserted under ultrasound guidance. Continuous aspira-
tion on the syringe is performed with the cannula in
constant motion in a radial pattern above the arterio-
venous fistula under direct ultrasound guidance. This
direct ultrasound mapping and guidance minimizes po-
tential complications, such as injury to the fistula or
disruption of small tributary veins. This technique is
performed on the overlying adipose tissue until the
fistula was easily palpable and visible pulsations were
noted underneath the skin. After thinning the tissue, the
fistula was examined using B mode duplex to ensure no
injury, pseudoaneurysm, or extravasation and spectral
duplex to confirm adequate flow through the fistula.
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Endovascular Treatment of Hemodialysis Access Pseu-
doaneurysms: A Single Institution Experience
Aamir S. Shah, Jaime Valdes, Kristofer M. Charlton-Ouw,
Zhongxue Chen, Sheila M. Coogan, Hammad M. Amer,
Anthony L. Estrera, Hazim J. Safi, Ali Azizzadeh. Cardio-
thoracic and Vascular Surgery, University of Texas Medical
School at Houston, Houston, TX
Objectives: Pseudoaneurysm (PSA) formation is a
complication of hemodialysis access. Open repair requires
PSA resection, interposition graft placement, and insertion
of a catheter as a bridge. Endovascular stent graft repair is
an alternative that permits immediate use of the access site.
The objective of this study was to determine the efficacy of
stent grafts for repair of arteriovenous fistula (AVF) and
graft (AVG) PSA.
Methods: A retrospective review of medical records
from October 2007 to December 2010 revealed 21 pa-
tients with a PSA who underwent endovascular repair using
a stent graft. Indications for repair included PSA with
symptoms (n 12), PSAwith skin erosion (n8), PSAwith
failed hemodialysis (n3), and PSA after balloon angio-
plasty of a stenosis (n1). Outcome measures were techni-
cal success, 30-day and 180-day patency, secondary inter-
ventions, and complications.
Results: Twenty-four self expanding stent grafts (Via-
bahn, WL Gore n22; Fluency, Bard n2) were used to
treat hemodialysis access (AVG n12, AVF n9) PSA in
21 patients (14 females, mean age55.3 yrs, mean
BMI28.3, mean PSA diameter 17.9 mm). Co-morbidi-
ties included hypertension (n19, 91.4%) and diabetes
mellitus (n8, 38.1%). The median time from access cre-
ation to repair was 455 days. The technical success rate was
100%. The 30 and 180 day patency rate was 100% and
69.2%, respectively. Two secondary interventions were per-
formed for treatment of unrelated stenosis. Treatment fail-
ure occurred in 5 (20.8%) stent grafts due to infection
(n3) and thrombosis (n2). Treatment of PSA with skin
erosion was associated with failure due to infection (OR
3.3, 95% CI 0.41, 26.34). The remaining 19 (79.2%) stent
grafts remain patent. The mean follow up time was 299
days (median 126).
Conclusions: Endovascular treatment of hemodialysis
access PSA using stent grafts is an effective and durable
option. PSA with skin erosion may increase the risk of
failure due to infection.
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SS17.
Hormone Replacement Therapy Is Associated with a
Decreased Prevalence of Peripheral Arterial Disease in
Postmenopausal Women
Caron B. Rockman, Thomas S. Maldonado, Glenn R.
Jacobowitz, Mark A. Adelman, Thomas S. Riles. Surgery,
New York University Medical School, New York, NY
Objectives: The effect of HRT for postmenopausal
women on peripheral atherosclerosis remains in question.
Our goal was to analyze the use of HRT in a large popula-
tion of postmenopausal women to determine its association
with the prevalence of PAD.
Methods: A prospective database of patients who
underwent vascular screening was used. Identification of
patients as postmenopausal, and their use of HRT was
based on questionnaires. PAD was noted if the ABI was
0.9.
Results: Analysis was performed on 847,982 postmeno-
pausal women; 433,178 (51.1%) reported having used HRT.
HRT patients were slightly older than patients who had not
used HRT (64.7 yrs vs. 64.3 yrs). HRT patients were signifi-
cantly more likely to be Caucasian (93.6% vs. 83.3%), to have
smoked cigarettes (42.8% vs. 40.6%), to have hypertension
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